4basebio PLC (88Q.DE) XETRA

6.70

+0.2(+3.08%)

Updated at December 23 05:35PM

Currency In EUR

4basebio PLC

Address

25 Norman Way

Cambridge,

United Kingdom of Great Britain and Northern Ireland

Phone

N/A

Sector

Healthcare

Industry

Biotechnology

Employees

101

First IPO Date

November 23, 2021

Key Executives

NameTitlePayYear Born
Heikki LanckrietChief Executive Officer, Chief Scientific Officer & Executive Director599,4561977
Amy WalkerChief Operating Officer & Director350,913N/A
David RothChief Financial Officer, Company Secretary & Executive Director430,3971967
Manja Hermina Elisabeth Maria BoermanExecutive Chair of the Board01966

Description

4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.